Showing results (1-10 of 33) with videos related to
Sort By:
Pageof 4
The Journal of Clinical Investigation|August 22, 2002
Improving chemotherapeutic drug penetration in tumors by vascular targeting and barrier alterationFlavio Curnis, Angelina Sacchi, Angelo CortiCancer Research|January 28, 2004
Coupling tumor necrosis factor-alpha with alphaV integrin ligands improves its antineoplastic activityFlavio Curnis, Anna Gasparri, Angelina Sacchi, et al.Cancer Research|October 7, 2004
Crucial role for interferon gamma in the synergism between tumor vasculature-targeted tumor necrosis factor alpha (NGR-TNF) and doxorubicinAngelina Sacchi, Anna Gasparri, Flavio Curnis, et al.Cancer Research|April 5, 2005
Targeted delivery of IFNgamma to tumor vessels uncouples antitumor from counterregulatory mechanismsFlavio Curnis, Anna Gasparri, Angelina Sacchi, et al.Small (Weinheim an Der Bergstrasse, Germany)|November 13, 2012
IsoDGR-tagged albumin: a new αvβ3 selective carrier for nanodrug delivery to tumorsFlavio Curnis, Angelina Sacchi, Renato Longhi, et al.Nano Research|May 27, 2016
NGR-tagged nano-gold: A new CD13-selective carrier for cytokine delivery to tumorsFlavio Curnis, Martina Fiocchi, Angelina Sacchi, et al.Cancer Research|February 19, 2008
Synergistic damage of tumor vessels with ultra low-dose endothelial-monocyte activating polypeptide-II and neovasculature-targeted tumor necrosis factor-alphaLuca Crippa, Anna Gasparri, Angelina Sacchi, et al.Cancer Research|July 30, 2011
Chromogranin A restricts drug penetration and limits the ability of NGR-TNF to enhance chemotherapeutic efficacyEleonora Dondossola, Anna Maria Gasparri, Barbara Colombo, et al.Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|January 7, 2006
Synergistic antitumor activity of cisplatin, paclitaxel, and gemcitabine with tumor vasculature-targeted tumor necrosis factor-alphaAngelina Sacchi, Anna Gasparri, Corrado Gallo-Stampino, et al.Cancer Research|February 7, 2002
Differential binding of drugs containing the NGR motif to CD13 isoforms in tumor vessels, epithelia, and myeloid cellsFlavio Curnis, Gianluigi Arrigoni, Angelina Sacchi, et al.Pageof 4